Topp MS, Gokbuget N, Zugmaier G, Stein AS, et al. Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab. Cancer 2020 Nov 3. doi: 10.1002/cncr.33298.
PMID: 33141929